Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1

被引:31
作者
Hofmann, C
Hüser, A
Lehnert, W
Strauss, M
机构
[1] HepaVec AG Gentherapie, D-13122 Berlin, Germany
[2] Humboldt Univ, Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
[3] Danish Canc Soc, Div Canc Biol, DK-2100 Copenhagen, Denmark
关键词
baculovirus vectors; hepatocytes; liver gene transfer; protection; soluble complement receptor;
D O I
10.1515/BC.1999.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Baculovirus-based vectors are efficient means for gene transfer into hepatocytes in vitro. However, gene transfer in vivo is hampered by inactivation of baculovirus by the complement system. In this study, we demonstrate protection of baculovirus vectors against complement-mediated inactivation through recombinant soluble complement receptor type 1 (sCR1). Blocking of only the alternative complement pathway by a mutant of sCR1 did not result in baculovirus survival in human serum. The data suggest the use of sCR1 as a potent drug to facilitate baculovirus-mediated gene transfer into hepatocytes in vivo.
引用
收藏
页码:393 / 395
页数:3
相关论文
共 20 条
[1]   Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein [J].
Barsoum, J ;
Brown, R ;
McKee, M ;
Boyce, FM .
HUMAN GENE THERAPY, 1997, 8 (17) :2011-2018
[2]   Baculovirus-mediated gene transfer into mammalian cells [J].
Boyce, FM ;
Bucher, NLR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2348-2352
[3]  
Crossen R., 1996, BACULOVIRUS EXPRESSI
[4]   Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system [J].
Hofmann, C ;
Strauss, M .
GENE THERAPY, 1998, 5 (04) :531-536
[5]   EFFICIENT GENE-TRANSFER INTO HUMAN HEPATOCYTES BY BACULOVIRUS VECTORS [J].
HOFMANN, C ;
SANDIG, V ;
JENNINGS, G ;
RUDOLPH, M ;
SCHLAG, P ;
STRAUSS, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10099-10103
[6]  
Hofmann C., 1998, GENE THER MOL BIOL, V1, P231
[7]   Controlling the complement system in inflammation [J].
Kirschfink, M .
IMMUNOPHARMACOLOGY, 1997, 38 (1-2) :51-62
[8]   LIPOSOME-INDUCED ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY DOES NOT REQUIRE IMMUNOGLOBULIN [J].
MARJAN, J ;
XIE, ZC ;
DEVINE, DV .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1192 (01) :35-44
[9]  
OREILLY OR, 1994, BACULOVIRUS EXPRESSI, P29
[10]   Site-specific integration in mammalian cells mediated by a new hybrid baculovirus adeno-associated virus vector [J].
Palombo, F ;
Monciotti, A ;
Recchia, A ;
Cortese, R ;
Ciliberto, G ;
La Monica, N .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5025-5034